Xilio Therapeutics (XLO) Q3 2024 Earnings

Aug 8Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.73
-0.48
-0.24
0

Details

Expected EPS
-0.23
Actual EPS
-0.24
Surprise EPS
-0.01
Surprise Percent
-4.35%

Description

⁨Xilio Therapeutics⁩ (⁦XLO⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts